First-cycle IVF fails more often than it succeeds, and that’s true even when everything appears to go well. For women under 35, live birth rates per cycle typically hover around 40-50%, meaning the majority of first attempts don’t result in a baby. The odds decline sharply with age. Understanding why can help you make sense of what happened and what might change in a second attempt.
Chromosomal Errors Are the Leading Cause
The single biggest reason any IVF cycle fails is that the embryo carries the wrong number of chromosomes, a condition called aneuploidy. These errors prevent the embryo from implanting or cause an early miscarriage, often before you’d even get a positive pregnancy test. Aneuploidy rates climb steeply with age: roughly 25% of embryos have chromosomal errors in women aged 25 to 30, more than 50% in women over 35, and nearly 90% by age 44.
This means that even if your clinic retrieves several eggs and fertilizes them successfully, a large proportion of the resulting embryos may be chromosomally abnormal. The embryo can look perfectly healthy under a microscope and still carry a fatal genetic error. Standard IVF without genetic screening is essentially a numbers game, and younger women have better odds simply because more of their embryos are chromosomally normal.
Preimplantation genetic testing (PGT-A) screens embryos for these errors before transfer. In one study comparing first frozen single-embryo transfers, live birth rates were 48.3% with PGT-A screening versus 34.7% without it. The test doesn’t fix the underlying problem, but it avoids transferring embryos that were never going to succeed.
Your Uterine Lining May Not Have Been Ready
Even a chromosomally normal embryo needs the right environment to implant. The uterine lining has a narrow window of receptivity, roughly days 20 to 24 of a natural cycle, when it transforms from a hostile surface into one that can accept an embryo. If the embryo arrives outside that window, implantation fails regardless of embryo quality.
Thickness matters too. Clinical pregnancy rates drop when the lining measures less than 7 millimeters, and live birth rates decline with each millimeter below 8 mm in fresh transfer cycles. Some women simply don’t build enough lining in response to the hormones used during stimulation, a problem that may not be apparent until the cycle is already underway.
There’s also growing evidence that the high hormone levels produced during ovarian stimulation can disrupt the lining’s receptivity. The supraphysiological estrogen levels and premature progesterone rise that sometimes occur in stimulated cycles can throw off the timing of that implantation window, creating a mismatch between when the embryo is ready and when the lining is ready to receive it. This is one reason many clinics now freeze all embryos from a stimulation cycle and transfer them in a later, more controlled cycle.
Sperm Quality Plays a Bigger Role Than Many Expect
IVF discussions tend to focus on eggs and embryos, but sperm DNA damage is a well-documented contributor to cycle failure. When sperm DNA fragmentation exceeds about 15%, clinical pregnancy rates start to drop. At 30% or higher, blastocyst formation rates fall, embryo quality declines, and miscarriage risk increases.
The tricky part is that standard semen analysis, the test most men get before IVF, measures count, motility, and shape. It doesn’t assess DNA integrity. A man can have a perfectly normal semen analysis while carrying significant DNA damage in his sperm. This means DNA fragmentation often goes undetected in a first cycle and only gets investigated after failure. Factors like age, smoking, heat exposure, infections, and oxidative stress all contribute to fragmentation, and some of these are modifiable between cycles.
Hidden Conditions That Only Surface After Failure
Some conditions that interfere with implantation produce no obvious symptoms beforehand. Silent endometriosis is a common example: tissue similar to the uterine lining grows outside the uterus, but without the characteristic pain that would prompt investigation. Many people with silent endometriosis don’t learn they have it until they struggle to conceive. The condition can affect egg quality, embryo development, and the uterine environment all at once.
Other conditions that may go undiagnosed before a first cycle include small uterine polyps, a thin septum dividing the uterine cavity, chronic low-grade endometrial inflammation, or fluid-filled fallopian tubes (hydrosalpinx) that can leak toxic fluid into the uterus. A failed first cycle often triggers more thorough diagnostic testing that uncovers these issues, giving the clinic a chance to address them before trying again.
Age Compounds Every Other Factor
Age affects nearly every variable in IVF simultaneously. Older eggs produce more aneuploid embryos. The uterine lining becomes less responsive. Even when a chromosomally normal embryo is transferred, age-related changes beyond aneuploidy appear to reduce live birth rates. Research on women 43 and older using their own eggs found a cumulative clinical pregnancy rate of just 5.9% after a first attempt, and no pregnancies at all in women 45 or older.
This doesn’t mean IVF can’t work for older women, but it does mean the first cycle is more likely a diagnostic round than a successful one. The information gathered from that cycle, including how many eggs were retrieved, how they fertilized, and how the embryos developed, becomes the foundation for adjusting the approach.
What Actually Changes for the Second Cycle
After a failed cycle, clinics typically review the stimulation protocol, embryo development patterns, and transfer conditions. Interestingly, a large study of nearly 18,000 frozen embryo transfer cycles found that simply switching between a hormone-controlled (programmed) protocol and a natural-cycle protocol made no meaningful difference in live birth rates. Women who switched from programmed to natural FET had a 42.1% live birth rate versus 40.7% for those who repeated the same protocol.
One exception stood out: women who switched from a programmed cycle to a true natural cycle (ovulating on their own, with no hormonal support for timing) saw live birth rates of 50.3%, compared to 40.7% for those who repeated the programmed approach. This suggests that for some women, the hormonal manipulation itself may be part of the problem.
More impactful changes between cycles often involve addressing newly discovered issues: treating endometriosis, correcting a hydrosalpinx, adding genetic testing to embryo selection, or investigating and treating sperm DNA fragmentation. The first cycle provides data that simply didn’t exist before, and that data is often more valuable than any single protocol tweak. For many couples, the first IVF cycle is as much a learning experience as it is a treatment attempt.